Improving the Efficacy of Cisplatin using Niosome Nanoparticles Against Human Breast Cancer Cell Line BT-20 : An In Vitro Study

Objective: Today, cancer is one the most important challenges in modern medicine. Meanwhile, breast cancer is one of the most common causes of mortality among cancers. The initial response to the treatment and then becoming resistant to the cisplatin is one of basal challenges of treatment of breast...

Full description

Bibliographic Details
Main Authors: Leila Kanaani, Maral Mazloumi Tabrizi, Azim Akbarzadeh Khiyavi, Iraj Javadi
Format: Article
Language:English
Published: West Asia Organization for Cancer Prevention 2017-06-01
Series:Asian Pacific Journal of Cancer Biology
Subjects:
Online Access:http://www.waocp.com/journal/index.php/apjcb/article/view/213
_version_ 1827370373538119680
author Leila Kanaani
Maral Mazloumi Tabrizi
Azim Akbarzadeh Khiyavi
Iraj Javadi
author_facet Leila Kanaani
Maral Mazloumi Tabrizi
Azim Akbarzadeh Khiyavi
Iraj Javadi
author_sort Leila Kanaani
collection DOAJ
description Objective: Today, cancer is one the most important challenges in modern medicine. Meanwhile, breast cancer is one of the most common causes of mortality among cancers. The initial response to the treatment and then becoming resistant to the cisplatin is one of basal challenges of treatment of breast cancer. Recently, using nanotechnology including drug nanocarrier named niosome can decrease adverse effects and increase the efficiency of treatment. Material and Methods: The aim of this research was to investigate using niosome nanoparticles containing cisplatin and investigation of their lethal effect on breast cancer cell line. Results: We found that using niosome nanoparticles can provide a suitable formulation of cisplatin drug. Conclusion: The efficiency of nanoniosome cisplatin was more than free drug, decreasing the administered dose and therefore the damage to other tissues.
first_indexed 2024-03-08T10:13:22Z
format Article
id doaj.art-1f2b34bb2ab24f729af684572606be7f
institution Directory Open Access Journal
issn 2538-4635
language English
last_indexed 2024-03-08T10:13:22Z
publishDate 2017-06-01
publisher West Asia Organization for Cancer Prevention
record_format Article
series Asian Pacific Journal of Cancer Biology
spelling doaj.art-1f2b34bb2ab24f729af684572606be7f2024-01-29T05:47:43ZengWest Asia Organization for Cancer PreventionAsian Pacific Journal of Cancer Biology2538-46352017-06-0122272910.31557/apjcb.2017.2.2.27-29213Improving the Efficacy of Cisplatin using Niosome Nanoparticles Against Human Breast Cancer Cell Line BT-20 : An In Vitro StudyLeila KanaaniMaral Mazloumi TabriziAzim Akbarzadeh KhiyaviIraj JavadiObjective: Today, cancer is one the most important challenges in modern medicine. Meanwhile, breast cancer is one of the most common causes of mortality among cancers. The initial response to the treatment and then becoming resistant to the cisplatin is one of basal challenges of treatment of breast cancer. Recently, using nanotechnology including drug nanocarrier named niosome can decrease adverse effects and increase the efficiency of treatment. Material and Methods: The aim of this research was to investigate using niosome nanoparticles containing cisplatin and investigation of their lethal effect on breast cancer cell line. Results: We found that using niosome nanoparticles can provide a suitable formulation of cisplatin drug. Conclusion: The efficiency of nanoniosome cisplatin was more than free drug, decreasing the administered dose and therefore the damage to other tissues.http://www.waocp.com/journal/index.php/apjcb/article/view/213nanoniosome- cisplatin- breast cancer
spellingShingle Leila Kanaani
Maral Mazloumi Tabrizi
Azim Akbarzadeh Khiyavi
Iraj Javadi
Improving the Efficacy of Cisplatin using Niosome Nanoparticles Against Human Breast Cancer Cell Line BT-20 : An In Vitro Study
Asian Pacific Journal of Cancer Biology
nanoniosome- cisplatin- breast cancer
title Improving the Efficacy of Cisplatin using Niosome Nanoparticles Against Human Breast Cancer Cell Line BT-20 : An In Vitro Study
title_full Improving the Efficacy of Cisplatin using Niosome Nanoparticles Against Human Breast Cancer Cell Line BT-20 : An In Vitro Study
title_fullStr Improving the Efficacy of Cisplatin using Niosome Nanoparticles Against Human Breast Cancer Cell Line BT-20 : An In Vitro Study
title_full_unstemmed Improving the Efficacy of Cisplatin using Niosome Nanoparticles Against Human Breast Cancer Cell Line BT-20 : An In Vitro Study
title_short Improving the Efficacy of Cisplatin using Niosome Nanoparticles Against Human Breast Cancer Cell Line BT-20 : An In Vitro Study
title_sort improving the efficacy of cisplatin using niosome nanoparticles against human breast cancer cell line bt 20 an in vitro study
topic nanoniosome- cisplatin- breast cancer
url http://www.waocp.com/journal/index.php/apjcb/article/view/213
work_keys_str_mv AT leilakanaani improvingtheefficacyofcisplatinusingniosomenanoparticlesagainsthumanbreastcancercelllinebt20aninvitrostudy
AT maralmazloumitabrizi improvingtheefficacyofcisplatinusingniosomenanoparticlesagainsthumanbreastcancercelllinebt20aninvitrostudy
AT azimakbarzadehkhiyavi improvingtheefficacyofcisplatinusingniosomenanoparticlesagainsthumanbreastcancercelllinebt20aninvitrostudy
AT irajjavadi improvingtheefficacyofcisplatinusingniosomenanoparticlesagainsthumanbreastcancercelllinebt20aninvitrostudy